These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12624152)

  • 1. The BRCA2 variant 8204G>A is a splicing mutation and results in an in frame deletion of the gene.
    Hofmann W; Horn D; Hüttner C; Classen E; Scherneck S
    J Med Genet; 2003 Mar; 40(3):e23. PubMed ID: 12624152
    [No Abstract]   [Full Text] [Related]  

  • 2. cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation.
    Zhang L; Bacares R; Boyar S; Hudis C; Nafa K; Offit K
    Mutat Res; 2009 Apr; 663(1-2):84-9. PubMed ID: 19070627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease.
    Plaschke J; Commer T; Jacobi C; Schackert HK; Chang-Claude J
    J Med Genet; 2000 Sep; 37(9):E17. PubMed ID: 10978364
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers.
    Ramalho AS; Beck S; Penque D; Gonska T; Seydewitz HH; Mall M; Amaral MD
    J Med Genet; 2003 Jul; 40(7):e88. PubMed ID: 12843337
    [No Abstract]   [Full Text] [Related]  

  • 6. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
    Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
    Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease.
    Sato S; Kamino K; Miki T; Doi A; Ii K; St George-Hyslop PH; Ogihara T; Sakaki Y
    Hum Mutat; 1998; Suppl 1():S91-4. PubMed ID: 9452052
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel germline in frame deletion (4128del3) of the BRCA2 gene detected in a breast/ovarian cancer family with fallopian tube and brain tumors identified in the north of France.
    Demange L; Noguchi T; Sauvan R; Moyal-Amsellem N; Birnbaum D; Eisinger F; Sobol H
    Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180606
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel BRCA2 germline mutations (1864 delT, 6132 del4, 8208 del5) detected in breast cancer families identified in the south of France.
    Noguchi T; Sauvan R; Moyal-Amsellem N; Boubli L; Eisinger F; Birnbaum D; Sobol H
    Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180605
    [No Abstract]   [Full Text] [Related]  

  • 11. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
    Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
    Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family.
    Diez O; Gutiérrez-Enríquez S; Masas M; Tenés A; Yagüe C; Arcusa A; Llort G
    Breast Cancer Res Treat; 2010 Sep; 123(2):587-90. PubMed ID: 20232139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.
    Thirthagiri E; Klarmann KD; Shukla AK; Southon E; Biswas K; Martin BK; North SL; Magidson V; Burkett S; Haines DC; Noer K; Matthai R; Tessarollo L; Loncarek J; Keller JR; Sharan SK
    Hum Mol Genet; 2016 May; 25(10):1934-1945. PubMed ID: 26920070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
    Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
    Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer.
    Hadiji-Abbes N; Trifa F; Choura M; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Pathol Biol (Paris); 2015 Sep; 63(4-5):185-9. PubMed ID: 26320393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.
    Nordling M; Karlsson P; Wahlström J; Engwall Y; Wallgren A; Martinsson T
    Cancer Res; 1998 Apr; 58(7):1372-5. PubMed ID: 9537232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.
    van der Luijt RB; van Zon PH; Jansen RP; van der Sijs-Bos CJ; Wárlám-Rodenhuis CC; Ausems MG
    J Med Genet; 2001 Feb; 38(2):102-5. PubMed ID: 11158174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.
    Zhi X; Szabo C; Chopin S; Suter N; Wang QS; Ostrander EA; Sinilnikova OM; Lenoir GM; Goldgar D; Shi YR
    Hum Mutat; 2002 Dec; 20(6):474. PubMed ID: 12442274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.